LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer combo trial halted early – what we know
Disease control TerminatedThis study tested a new pill (SLC-391) combined with an immunotherapy drug (pembrolizumab) in people with advanced non-small cell lung cancer. The goal was to find a safe dose and see if the combination could shrink tumors. The trial was terminated early, so results are limited. …
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Lung cancer brain metastasis study halted after just 3 patients
Disease control TerminatedThis study tested whether adding the drug pembrolizumab to chemotherapy could help people with non-small cell lung cancer that has spread to the brain but is not causing symptoms. The goal was to see if the combination could control the cancer in the brain and improve survival. H…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
Could a cholesterol drug boost lung cancer immunotherapy?
Disease control TerminatedThis study looked at adding evolocumab (a cholesterol-lowering drug) to standard immunotherapy (nivolumab and ipilimumab) for people with advanced non-small cell lung cancer. The goal was to see if the combination was safe and could help the immune system fight cancer better. The…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Eziafa Oduah, MD, PhD, MPH • Aim: Disease control
Last updated May 20, 2026 11:55 UTC